LATEST NEWS
NeuroDelta presents at EPIC Biotechnology Conference... More here

Paper archives

The following research papers have all appeared in independent academic and research journals. They are a representative selection of the published material detailing the research behind NeuroDelta's current activities.

MILTON, N.G.N. (2004) Role of hydrogen peroxide in the aetiology of Alzheimer’s Disease: implications for treatment. Drugs Aging, 21, 81-100.

MILTON, N.G.N. (2002) Anandamide and noladin ether prevent neurotoxicity of the human amyloid-β peptide. Neurosci. Lett., 332, 127-30.

MILTON, N.G.N. (2002) The amyloid-β peptide binds to cyclin B1 and increases human cyclin-dependent kinase-1 activity. Neurosci. Lett., 322, 131-3.

MILTON, N.G.N. (2001) Inhibition of catalase activity with 3-amino-triazole enhances the cytotoxicity of the Alzheimer s amyloid-β peptide. NeuroToxicology 22,767-74.

MILTON, N.G.N. (2001) Phosphorylation of amyloid-β at the serine 26 residue by human cdc2 kinase. NeuroReport 12, 3839-44.

MILTON, N.G.N., Mayor, N.P. & Rawlinson, J. (2001) Identification of amyloid-β binding sites using an antisense peptide approach. NeuroReport, 12, 2561-6.

MILTON, N.G.N. (1999) Amyloid-b binds catalase with high affinity and inhibits hydrogen peroxide breakdown. Biochem. J., 344, 293-6.

[HOME] [COMPANY] [RESEARCH] [APPLICATIONS] [NEWS] [CONTACT]